NELFINAVIR Side Effects

6268416-9 | Cough, Dyspnoea, Fatigue, Haemoptysis, Metastases To Lung, Poor Quality Sleep, Tracheal Neoplasm, Weight Decreased
on Jul 09, 2009 Male patient from UNITED STATES , weighting 162.7 lb, was diagnosed with liposarcoma, metastases to lung and was treated with Nelfinavir (View Usage). Patient experienced the following unwanted or unexpected effects: cough, dyspnoea, fatigue, haemoptysis, metastases to lung, poor quality sleep, tracheal neoplasm, weight decreased. Nelfinavir dosage: 3000mg Twice Daily Po.

6200357-5 |
Patient was taking Nelfinavir (View Usage). on May 12, 2009 from UNITED STATES Additional patient health information: Female patient , 38 years of age, . Nelfinavir dosage: . During the same period patient was treated with LAMIVUDINE AND ZIDOVUDINE (Started At Week 8 Of Amenorrhea) (View Lamivudine And Zidovudine Review and Lamivudine And Zidovudine Label ), RITONAVIR (Started In Week 8 Of Amenorrhea) (View Ritonavir Review and Ritonavir Label ), TENOFOVIR (View Tenofovir Review and Tenofovir Label ).

5603883-2 | Ascites, Dehydration, Liposarcoma Recurrent, Malignant Neoplasm Progression, Pleural Effusion, Respiratory Failure
Adverse event was reported on Jan 25, 2008 by a Male patient taking Nelfinavir (View Usage) (Dosage: 2125 Mg Bid) . Location: UNITED STATES , 54 years of age, After Nelfinavir was administered, patient had the following side effects: ascites, dehydration, liposarcoma recurrent, malignant neoplasm progression, pleural effusion, respiratory failure.

5601885-3 | Threatened Labour
on Jan 16, 2008 Female patient from JAPAN , 34 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Nelfinavir (View Usage). Patient experienced the following unwanted or unexpected effects: threatened labour. Nelfinavir dosage: Daily Dose:2500mg-freq:interval: Everyday. During the same period patient was treated with RETROVIR (Daily Dose:400mg-freq:interval: Everyday) (View Retrovir Review and Retrovir Label ), EPIVIR (View Epivir Review and Epivir Label ), FERROUS FUMARATE (View Ferrous Fumarate Review and Ferrous Fumarate Label ), LOPERAMIDE HYDROCHLORIDE (View Loperamide Hydrochloride Review and Loperamide Hydrochloride Label ). Patient was hospitalized.


5256939-0 | Depressed Level Of Consciousness, Hypercapnia, Post Procedural Complication, Respiratory Failure
on Mar 05, 2007 Male patient from UNITED STATES , 76 years of age, weighting 213.8 lb, was diagnosed with liposarcoma and was treated with Nelfinavir (View Usage). Patient had the following side effects: depressed level of consciousness, hypercapnia, post procedural complication, respiratory failure. Nelfinavir dosage: 2500 Mg Bid Po. Patient was hospitalized.

5173166-6 | Blood Alkaline Phosphatase Increased, Blood Creatinine Increased, Blood Potassium Increased, Blood Urea Increased, Disease Progression, Disease Recurrence, Pancreatitis
Patient was taking Nelfinavir (View Usage). After Nelfinavir was administered, patient had the following side effects: blood alkaline phosphatase increased, blood creatinine increased, blood potassium increased, blood urea increased, disease progression, disease recurrence, pancreatitis on Dec 08, 2006 from UNITED STATES Additional patient health information: Male patient , 72 years of age, weighting 148.2 lb, was diagnosed with liposarcoma and. Nelfinavir dosage: 1250 Mg Po Bid. Patient was hospitalized.